| Serial Number | 85261936 |
| Word Mark | JOVOLA |
| Filing Date | Wednesday, March 9, 2011 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, July 16, 2021 |
| Registration Number | 4651130 |
| Registration Date | Tuesday, December 9, 2014 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 23, 2014 |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Pharmaceutical preparations, namely, pharmaceutical preparations and substances for the treatment of skin disorders, diseases, conditions and ailments; pharmaceutical preparations and products for use in dermatology; antifungal preparations; pharmaceutical preparations and substances for the treatment of eye disorders, diseases, conditions and ailments; pharmaceutical preparations and products for ophthalmological use; pharmaceutical preparations and substances for the treatment of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety, depression, depressive disorders and mental illness; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardiovascular system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of Parkinson's disease; pharmaceutical preparations and substances for the prevention, treatment and alleviation of Huntington's disease; pharmaceutical preparations and substances for the prevention, treatment and alleviation of amyotropic lateral sclerosis; pharmaceutical preparations and substances for the prevention, treatment and alleviation of Alzheimer's disease; pharmaceutical preparations and substances for the prevention, treatment and alleviation of Tourette Syndrome; pharmaceutical preparations and substances for the prevention, treatment and alleviation of epilepsy; pharmaceutical preparations and substances for the prevention, treatment and alleviation of multiple sclerosis; pharmaceutical preparations and substances for the prevention, treatment and alleviation of cardio-pulmonary disorders, diseases, conditions, and ailments; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions, and ailments of the circulatory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension, high blood pressure, heart filure and ventricular dysfunction; pharmaceutical preparations and substances for the prevention, treatment and alleviation of metabolic disorders, diseases, conditions and ailments; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of viral and infectious diseases; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of central nervous system disorders, diseases, conditions and ailments, namely, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, cerebral palsy, insomnia, mood disorders, bipolar disorder, seizure disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; pharmaceutical preparations for the treatment of immunologic diseases, namely, auto immune motility diseases, immunologic deficiency syndromes, auto immune diseases, Acquired Immune Deficiency Syndrome (AIDS), hypersensitivity, allergies, tumors of the immunological organs; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculoskeletal system, namely, bone diseases and bone degenerative conditions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for the treatment of polycystic ovary syndrome; pharmaceutical preparations and substances for the treatment of infertility; metformin; diltiazem; tramadol; carvedilol; bupropion; metoprolol; citalopram; zolpidem; fluoxetine; venlafaxine; lorazepam; and sumatriptan |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, July 16, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | BAUSCH HEALTH IRELAND LIMITED |
| Party Type | 33 - New Owner After Registration |
| Legal Entity Type | 99 - Other |
| Address | DUBLIN 24 IE |
| Party Name | VALEANT PHARMACEUTICALS IRELAND LIMITED |
| Party Type | 32 - New Owner After Registration |
| Legal Entity Type | 99 - Other |
| Address | DUBLIN 24 IE |
| Party Name | VALEANT PHARMACEUTICALS LUXEMBOURG S.À.R.L |
| Party Type | 31 - New Owner After Registration |
| Legal Entity Type | 99 - Other |
| Address | LUXEMBOURG CITY 1931 LU |
| Party Name | VALEANT INTERNATIONAL (BARBADOS) SRL |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | CHRIST CHURCH BB17154 BB |
| Party Name | VALEANT INTERNATIONAL (BARBADOS) SRL |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | CHRIST CHURCH BB17154 BB |
| Party Name | VALEANT INTERNATIONAL (BARBADOS) SRL |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 99 - Other |
| Address | CHRIST CHURCH BB17154 BB |
| Party Name | Biovail Laboratories International SRL |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Christ Church BB17154 BB |
| Event Date | Event Description |
| Friday, July 16, 2021 | CANCELLED SEC. 8 (6-YR) |
| Sunday, May 3, 2020 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Sunday, May 3, 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Sunday, May 3, 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Sunday, May 3, 2020 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Sunday, May 3, 2020 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, December 9, 2019 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Wednesday, July 10, 2019 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Wednesday, March 20, 2019 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Tuesday, October 16, 2018 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, October 16, 2018 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, February 21, 2018 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Wednesday, January 11, 2017 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Thursday, March 3, 2016 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, January 21, 2015 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Tuesday, December 9, 2014 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, September 23, 2014 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 23, 2014 | PUBLISHED FOR OPPOSITION |
| Wednesday, September 3, 2014 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, August 19, 2014 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Monday, August 18, 2014 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, July 30, 2014 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, July 30, 2014 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, July 30, 2014 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, February 14, 2014 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, February 14, 2014 | NON-FINAL ACTION E-MAILED |
| Friday, February 14, 2014 | NON-FINAL ACTION WRITTEN |
| Wednesday, January 22, 2014 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, January 22, 2014 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, January 15, 2014 | LIE CHECKED SUSP - TO ATTY FOR ACTION |
| Saturday, July 13, 2013 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Wednesday, January 9, 2013 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Wednesday, August 1, 2012 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Friday, July 6, 2012 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Friday, July 6, 2012 | LETTER OF SUSPENSION E-MAILED |
| Friday, July 6, 2012 | SUSPENSION LETTER WRITTEN |
| Wednesday, June 27, 2012 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, June 26, 2012 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, June 26, 2012 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Wednesday, June 27, 2012 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Wednesday, June 27, 2012 | ASSIGNED TO LIE |
| Thursday, December 15, 2011 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Thursday, December 15, 2011 | LETTER OF SUSPENSION E-MAILED |
| Thursday, December 15, 2011 | SUSPENSION LETTER WRITTEN |
| Thursday, December 15, 2011 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, December 15, 2011 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, December 15, 2011 | ASSIGNED TO LIE |
| Friday, December 9, 2011 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, June 9, 2011 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, June 9, 2011 | NON-FINAL ACTION E-MAILED |
| Thursday, June 9, 2011 | NON-FINAL ACTION WRITTEN |
| Thursday, June 9, 2011 | ASSIGNED TO EXAMINER |
| Wednesday, April 6, 2011 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Monday, March 14, 2011 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Saturday, March 12, 2011 | NEW APPLICATION ENTERED IN TRAM |